• Corpus ID: 49222720

Pilot Clinical Study on a Proprietary Elderberry Extract : Efficacy in Addressing Influenza Symptoms

@inproceedings{PilotCS,
  title={Pilot Clinical Study on a Proprietary Elderberry Extract : Efficacy in Addressing Influenza Symptoms},
  author={},
  url={https://api.semanticscholar.org/CorpusID:49222720}
}
  • Medicine
omicron-pharma.com
35 Citations
Highly Influential Citations
4
Background Citations
17
Methods Citations
5
Results Citations
2

Figures from this paper

35 Citations

Elderberry for prevention and treatment of viral respiratory illnesses: a systematic review

Elderberry may be a safe option for treating viral respiratory illness, and there is no evidence that it overstimulates the immune system, but the evidence on both benefits and harms is uncertain and information from recent and ongoing studies is necessary to make firm conclusions.

An Evidence-Based Systematic Review of Elderberry and Elderflower (Sambucus nigra) by the Natural Standard Research Collaboration

An evidence-based systematic review of elderberry and elderflower by the Natural Standard Research Collaboration consolidates the safety and efficacy data available in the scientific literature using a validated, reproducible grading rationale.

The effects of Sambucus nigra berry on acute respiratory viral infections: A rapid review of clinical studies

Elderberry Supplementation Reduces Cold Duration and Symptoms in Air-Travellers: A Randomized, Double-Blind Placebo-Controlled Clinical Trial

Data suggest a significant reduction of cold duration and severity in air travelers, and more research is warranted to confirm this effect and to evaluate elderberry’s physical and mental health benefits.

A Concise Review: Nutritional Interventions for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

The authors summarize the complex interaction between nutritional status and severe acute respiratory syndrome corona virus 2 infections, as well as the consequences of poor nutrients with regard of the extent to which disease is affected.

Flavonoids for Treating Viral Acute Respiratory Tract Infections: A Systematic Review and Meta-Analysis of 30 Randomized Controlled Trials

Results from this systematic review and meta-analysis suggested that flavonoids were efficacious and safe in treating viral ARTIs including the common cold, influenza, COVID−19, acute non-streptococcal tonsillopharyngitis, acute bronchitis, bronchial pneumonia, and upper respiratory tract infections.

Flavonoids for Treating Viral Acute Respiratory Tract Infections: A Systematic Review and Meta-Analysis of 30 Randomized Controlled Trials

A systematic review and meta-analysis showed that flavonoids were efficacious and safe in treating viral ARTIs including the common cold, influenza, COVID-19, acute non-streptococcal tonsillopharyngitis, acute bronchitis, bronchial pneumonia, and upper respiratory tract infections.

Efficacy of the commercial plant products acting against influenza-a review

The present review documents the successfully launched anti-influenza commercial products and exposes the scientifically validated and evidence-based supporting inhibitory action of influenza and its strains.

Evaluation of botanicals as potential COVID-19 symptoms terminator

Herbal therapies were identified as potential options for both antiviral effects and control of COVID-19 symptoms, before determining the effects of plants on severe acute respiratory syndrome coronavirus 2.

Can nutraceuticals assist treatment and improve covid-19 symptoms?

Quercetin, astaxanthin, luteolin, glycyrrhizin, lactoferrin, hesperidin and curcumin have shown encouraging data suggesting their use to prevent and counteract the symptoms of this pandemic infection.

3 References

Rational design of potent sialidase-based inhibitors of influenza virus replication

Two potent inhibitors based on the crystal structure of influenza virus sialidase have been designed and provide an example of the power of rational, computer-assisted drug design, indicating significant progress in the development of a new therapeutic or prophylactic treatment for influenza infection.

Resistance of influenza A virus to amantadine and rimantadine: results of one decade of surveillance.

Although this resistant influenza was transmitted and caused illness in one family, the absence of naturally occurring resistant viruses suggests that the emergence of new strains of influenza A each few years may prevent the widespread emergence of resistant influenza A virus.

Clinical efficacy and safety of the orally inhaled neuraminidase inhibitor zanamivir in the treatment of influenza: a randomized, double-blind, placebo-controlled European study.

Zanamivir is effective in reducing the duration and severity of influenza illness and is well tolerated, and should be a clinically valuable intervention in the management of influenza.